↓ Skip to main content

Dove Medical Press

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2009
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
39 Mendeley
Title
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
Published in
Neuropsychiatric Disease and Treatment, August 2009
DOI 10.2147/ndt.s6873
Pubmed ID
Authors

Jan K Buitelaar, J Antoni Ramos-Quiroga, Miguel Casas, J J Sandra Kooij, Asko Niemelä, Eric Konofal, Joachim Dejonckheere, Bradford H Challis, Rossella Medori

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Brazil 1 3%
France 1 3%
United Kingdom 1 3%
Sweden 1 3%
Unknown 33 85%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 15%
Other 4 10%
Student > Master 4 10%
Student > Bachelor 4 10%
Student > Doctoral Student 3 8%
Other 9 23%
Unknown 9 23%
Readers by discipline Count As %
Medicine and Dentistry 14 36%
Psychology 6 15%
Computer Science 3 8%
Neuroscience 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 8%
Unknown 10 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,151
of 3,132 outputs
Outputs of similar age
#41,920
of 122,468 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#5
of 9 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,468 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.